Share
Lung Cancer Surgery Market: By Surgical Devices (Surgical Instruments, Monitoring & Visualizing Systems, Endosurgical Equipment), By Surgical Procedures (Thoracotomy, Minimally Invasive Surgeries), By End User (Hospitals, Ambulatory Surgical Centers), And Region - Global Analysis of Market Size, Share & Trends For 2021-2022 And Forecasts To 2032
Lung cancer surgery is performed on some patients on the basis of the type, the area of surgery, and stage of their lung cancer and other medical disorders. Surgery is not advised for all patients with lung cancer, some need partial while others need complete lung removal. Surgery is used to treat the severe lung cancer. This involves removing the tumor, a few lung tissues around it, and frequently some lymph nodes as well. When lung cancer is limited and does not tend to spread, surgery to remove the tumor is thought to be the best option. This includes carcinoid tumors and non-small cell lung cancer in its early stages.
Lung Cancer Surgery to surpass USD 6.8 Billion by 2032 from USD 4.14 Billion in 2021 at a CAGR of 4.7% in the coming years, i.e., 2022-32. The global market for lung cancer surgery is anticipated to grow over the forecast period due to factors, such as growing air pollution levels and an increase in cigarette smokers. Another fueling factor of the market is the significant investment in research laboratories, rising air pollution levels, rising smoking rates, and advantageous reimbursement policies, particularly in industrialized nations.
Get extra information of this Report : Request Free Sample Pages
LUNG CANCER SURGERY MARKET: SEGMENTS
Lung Cancer Surgery market is categorized on the basis of Surgical Devices into Surgical Instruments, Monitoring & Visualizing Systems, and Endosurgical Equipment. The surgical instruments market category held the maximum market share in 2020. The factors driving the segment growth are the rising incidence and prevalence of lung cancer, the increased government funding and support, and the growing use of surgical methods for lung cancer therapy.
Lung Cancer Surgery market is categorized on the basis of Surgical Procedures into Thoracotomy and Minimally Invasive Surgeries. The market for lung cancer surgery was dominated by the thoracotomy sector in 2020. However, the category for minimally invasive surgeries is anticipated to experience the fastest growth during the projection period. The reasons driving the growth of this market segment include the rising acceptance of minimally invasive procedures, rising technical breakthroughs, the availability of reimbursement policies, and the rising popularity of robotic surgeries.
Get extra information of this Report : Request Free Sample Pages
MARKET DYNAMICS
One of the main reasons for the rise of the lung cancer surgery market is the increase in air pollution and the number of people affected by it. According to the research, lung cancer is the leading cause of cancer-related deaths on the global scale. Due to the vast patient pool and demand for effective treatment, it is also anticipated that the rising occurrences of lung cancer will contribute to the demand for lung cancer surgery instruments. With the rise in heavy smoking, environmental pollution, and workplace exposures in milling, construction, and auto repair shops, lung cancer cases are increasing speedily. Another well-known and evident risk factor for lung cancer is smoking cigarettes.
The demand for lung cancer surgery is predicted to increase in the next years due to the rise of cutting-edge medical technology and the introduction of high-tech surgical energy devices. Lung resection procedures have increased in frequency as a result of the enhanced device versatility and ease of use in complex cases brought on by new endoscopic and surgical tools. The development of the global lung cancer surgery market has been positively impacted by the advancement of technology.
High-cost lung cancer surgeries include lobectomy, wedge resection, and other procedures. For a sizable population, the cost of endoscopy and video-assisted lung surgical operations is a serious issue. This is since in low-economic nations like South Africa, India, and China, video-assisted surgeries are not covered by health insurance, and there is little government support for them. The market for lung cancer surgery is also anticipated to develop slowly due to post-operation infections and dangers connected with lung surgery. Some patients who have lung resection treatments frequently experience numerous post-operative problems and infections. The most frequent side effect of lung resection is air leak.
Company Overview, Business Strategy, Key Product Offerings, Financial Performance, Key Performance Indicators, Risk Analysis, Recent Development, Regional Presence, SWOT Analysis
Lung Cancer Surgery market is segmented based on regional analysis into five major regions: North America, Latin America, Europe, Asia Pacific and the Middle East and Africa. North America held the larger market share in 2020. The large segment of lung cancer cases in North America can be attributed to rising technological developments in the management of the disease, growing incidence and prevalence of lung cancer, rising tobacco use, growing emphasis on early cancer detection and treatment, and the availability of reimbursement.
Asia-Pacific is also anticipated to be the most lucrative market due to the rising patient awareness levels, region's fast evolving healthcare infrastructure, and adoption of technologically advanced robotic procedures in Japan and the expanding economies of India and China.
The coronavirus pandemic presented an unprecedented challenge to the global healthcare systems, particularly in the care of cancer patients. Numerous lung cancer patients postponed follow-up appointments or routine anticancer treatments after the disease's emergence out of concern over the spread of the illness. The severe effects of the pandemic on oncological care have hampered the prospects for the sector in recent months. However, COVID-19 disease-related health issues, which over time caused significant harm to organs including the lungs, supported industry recovery after lower Coronavirus risk.
|
REPORT ATTRIBUTE |
DETAILS |
|
Market size value in 2021 |
USD 4.14 Billion |
|
Revenue forecast in 2032 |
USD 6.8 Billion |
|
Growth Rate |
CAGR of 4.7% from 2022 to 2032 |
|
Base year for estimation |
2021 |
|
Quantitative units |
Revenue in USD million and CAGR from 2022 to 2032 |
|
Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
|
Segments covered |
Surgical Devices, Surgical Procedures, End User, and Region |
|
Regional scope |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa (MEA) |
|
Key companies profiled
|
Boston Scientific, Johnson & Johnson, Medtronic Private Limited, Olympus Corporation, Intuitive Surgical Inc., /KLS Martin Group, KARL STORZ SE & Co. KG, Accuray Inc, Ackermann Instrumente GmbH, Trokamed GmbH, Teleflex Incorporated, Ethicon Inc., AngioDynamics, Scanlan International Inc., FusionKraft, and Other Prominent Players. |
The Lung Cancer Surgery market size was estimated at USD 4.14 Billion in 2021 and is expected to reach USD 6.8 Billion in 2032.
Lung cancer is the cancer that originates in the lungs, where the first tumors appear and the patient has respiratory difficulties. In the entire world, it is the cancer that is most frequently found. A surgical technique or procedure is used to remove a lung tumor.
The Surgical Instruments and Minimally Invasive Surgeries segments accounted for the larger share of the Lung Cancer Surgery Market.
Key players in the Lung Cancer Surgery market are Boston Scientific, Johnson & Johnson, Medtronic Private Limited, Olympus Corporation, Intuitive Surgical Inc., /KLS Martin Group, KARL STORZ SE & Co. KG, Accuray Inc, Ackermann Instrumente GmbH, Trokamed GmbH, Teleflex Incorporated, Ethicon Inc., AngioDynamics, Scanlan International Inc., FusionKraft, and Other Prominent Players.
The rise in lung cancer prevalence and incidence, the inclination to smoke more, the aging population, the growing emphasis on early cancer detection and treatment, and the availability of reimbursement are all factors that are propelling the growth of the Lung Cancer Surgery Market.
Select License Type
Select License Type
FATPOS CLIENT Appriciation DURING THE PROJECT
Working with Fatpos Global, allowed us to take advantage of their knowledge and easy approach, allowing us to collect important data utilizing a variety of techniques. The results were clearly presented and explained, and FG responded to our questions with speed and expertise.
|
Swiss-based global building materials manufacturer |
The analyses and presentations Fatpos Global have produced for us have been of a very high caliber and have allowed us to proactively improve our customer relationship management. They have also done so while maintaining complete anonymity. Without any doubt, we suggest Fatpos Global to you.
|
|
Tech-powered construction company |
We appreciate the team’s punctuality, flexibility in terms of report modification, post report purchase support and pleasant reaction all around. Overall, my experience with this company was nothing but positive, and I couldn't be more grateful for their excellent service. Thank you for all that you do!
|
|
American global management consulting firm |
We are able to concentrate on the topics and implications that are most important to our clients thanks to the adaptability and responsiveness of the team at Fatpos Global. We would highly recommend this company to anyone in need of their services, and I will certainly be using them again in the future.
|
|
Headquartered in Zug, Switzerland, leading supplier of medical and surgical instrument |
To better study our client demographics, develop the ideal product-price architecture, and enhance our target marketing initiatives, we hired Fatpos Global. Every component of the project was completed, and we are very happy with the useful insights and actionable results.
|
|
Kosovan company, A leading organic fertilizers producer |
Thank you for your team's generous assistance, The final report was delivered to me, and I find it to be really helpful. Also, you may be sure that I will get in touch with you if I ever require fresh materials for market research. Gratitude once more.
|
|
German specialty chemicals company based in Cologne, Germany |
